Showing results (201-210 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 27, 2012
The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostimRobert Deuson, Mark Danese, Susan D Mathias, et al.Journal of Medical Economics|May 9, 2012
Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011K N Simpson, R W Baran, D Collomb, et al.Journal of Medical Economics|May 9, 2012
Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agentsXin Gao, Daniel Wendling, Marc F Botteman, et al.Journal of Medical Economics|January 3, 2012
Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystoniaKapil D Sethi, Ramon Rodriguez, Babajide OlayinkaJournal of Medical Economics|November 26, 2011
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United StatesVernon F Schabert, Crystal Watson, Shravanthi R Gandra, et al.Journal of Medical Economics|November 21, 2012
Laparoscopic adjustable gastric banding vs standard medical management in obese patients with type 2 diabetes: a budget impact analysis in the UKR F Pollock, J Chilcott, G Muduma, et al.Journal of Medical Economics|September 28, 2011
Economic impact of tobramycin in patients with cystic fibrosis in a managed care populationDebra A Wertz, Chun-Lan Chang, Judith J Stephenson, et al.Journal of Medical Economics|October 11, 2011
Health-related quality-of-life in patients after elective surgery for abdominal aortic aneurysmLars Ehlers, Kathrine Bang Laursen, Morten Berg JensenJournal of Medical Economics|July 7, 2011
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UKJulia Lowin, Annika Bergman, K Ray Chaudhuri, et al.Journal of Medical Economics|October 15, 2011
Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patientsFred Poordad, Dickens Theodore, Jane Sullivan, et al.Pageof 241